600750.SH
China Resources Jiangzhong Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 21.90
−0.68%Oct 23, 2026, 08:38 UTC
China Resources Jiangzhong reported first-three-quarter revenue of 2.662 billion yuan, down 9.25% year over year, and net profit of 617 million yuan, down 9.68%.
Source:Oct 23, 2026, 08:38 UTC
China Resources Jiangzhong reported third-quarter revenue of 730 million yuan, down 7.88% year over year, and net profit of 126 million yuan, down 21.84%.
Source:Oct 16, 2026, 10:18 UTC
China's National Medical Products Administration issued China Resources Jiangzhong a drug registration certificate for Shaoyao Gancao Tang Granules, with each sachet equivalent to 27.6 g of decoction pieces.
Sep 10, 2026, 08:21 UTC
China Resources Jiangzhong received a traditional Chinese medicine registration certificate (No. MAC-C00615) from Macao's Pharmaceutical Administration Bureau for its Jianwei Xiaoshi tablets, allowing sales in Macao.
Aug 21, 2026, 10:31 UTC
China Resources Jiangzhong announced its first-half 2026 results: net profit attributable to shareholders was 491 million yuan, down 5.92% year-on-year.
Source:Aug 21, 2026, 10:31 UTC
China Resources Jiangzhong proposed a cash dividend of 5 yuan per 10 shares, totaling 318 million yuan.
Source:Aug 3, 2026, 04:21 UTC
China Resources Pharmaceutical's subsidiary China Resources Jiangzhong Pharmaceutical obtained regulatory approval from China's State Administration for Market Regulation for two new special medical foods, expanding its portfolio to four registered products.
Source: